| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |